Howdy all...Anybody following GB?When I took the plunge into direct investing earlier this year, this was the first stock I bought.I'm still pleased with that... from my novice view this seems to be a very solid company, with few serious competitors, in a market sure to be on the rise.If AICD use begins to climb (as recent medical research suggests more benefit), that can only translate into higher revenues for GB -- right??
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst